← Leaderboards
Jess G Thoene
University Of Michigan At Ann Arbor
$3,417
Attributed
$3,417
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,417 · 4
By mechanism
M01$3,417 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Theodore S Lawrence$30,022,406
- Jeffrey S Chamberlain$54,800,495
- Max S. Wicha$49,028,071
- Matthias Kretzler$40,447,062
- Shaomeng Wang$36,139,079
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchMetabolism Disorder ChemotherapyDrug Screening /EvaluationInborn Metabolism DisorderPathologic ProcessHuman Therapy EvaluationPharmacokineticsDrug MetabolismEnzyme InhibitorsEnzyme TherapyFabry'S DiseaseHepatocellular CarcinomaIsozymesKidney Disorder ChemotherapyKidney FunctionKidney PharmacologyOxygenasesPediatric PharmacologyThiocyanatesAlpha FetoproteinTyrosinemiasAlpha GalactosidaseAminoacid Metabolism
Grant awards (5)
TK019: A Study of Replagal Enzyme Replacement Therapy$3,005
M01 · FY2004 · RR
Study and treatment of inborn error of metabolism$0
M01 · FY2002 · RR
NTBC THERAPY OF TYROSINEMIA TYPE I$206
M01 · FY2000 · RR
AMINOTHIOL THERAPY IN NEPHROPATHIC CYSTINOSIS$206
M01 · FY2000 · RR
Study and treatment of inborn error of metabolism$0
M01 · FY2000 · RR